Li H, Loehrer P J, Hisada M, Henley J, Whitby D, Engels E A
Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, 6120 Executive Blvd., EPS 8010, Rockville, MD 20892, USA.
Br J Cancer. 2004 Jun 1;90(11):2181-5. doi: 10.1038/sj.bjc.6601841.
The cause of thymoma, a rare malignancy of thymic epithelial cells, is unknown. Recent studies have reported the detection of DNA from human T-cell lymphotropic virus type I (HTLV-I) and human foamy virus (HFV) in small numbers of thymoma tumours, suggesting an aetiologic role for these retroviruses. In the present study, we evaluated 21 US thymoma patients and 20 patients with other cancers for evidence of infection with these viruses. We used the polymerase chain reaction to attempt to amplify viral DNA from tumour tissues, using primers from the pol and tax (HTLV-I) and gag and bel1 (HFV) regions. In these experiments, we did not detect HTLV-I or HFV DNA sequences in any thymoma or control tissues, despite adequate sensitivity of our assays (one HTLV-I copy per 25 000 cells, one HFV copy per 7500 cells). Additionally, none of 14 thymoma patients evaluated serologically for HTLV I/II infection was positive by enzyme-linked immunoassay (ELISA), while five (36%) had indeterminate Western blot reactivity. In comparison, one of 20 US blood donors was HTLV-I/II ELISA positive, and nine (45%) donors, including the ELISA-positive donor, had indeterminate Western blot reactivity. Western blot patterns varied across individuals and consisted mostly of weak reactivity. In conclusion, we did not find evidence for the presence of HTLV-I or HFV in US thymoma patients.
胸腺瘤是胸腺上皮细胞的一种罕见恶性肿瘤,其病因尚不清楚。最近的研究报告称,在少数胸腺瘤肿瘤中检测到了I型人类嗜T细胞病毒(HTLV-I)和人类泡沫病毒(HFV)的DNA,提示这些逆转录病毒在病因学上具有一定作用。在本研究中,我们评估了21例美国胸腺瘤患者和20例其他癌症患者,以寻找这些病毒感染的证据。我们使用聚合酶链反应,尝试从肿瘤组织中扩增病毒DNA,所用引物来自pol和tax(HTLV-I)区域以及gag和bel1(HFV)区域。在这些实验中,尽管我们的检测方法具有足够的灵敏度(每25000个细胞中有一个HTLV-I拷贝,每7500个细胞中有一个HFV拷贝),但在任何胸腺瘤或对照组织中均未检测到HTLV-I或HFV DNA序列。此外,在14例接受HTLV I/II感染血清学评估的胸腺瘤患者中,酶联免疫吸附测定(ELISA)均为阴性,而有5例(36%)的免疫印迹反应结果不确定。相比之下,20例美国献血者中有1例ELISA检测HTLV-I/II呈阳性,包括该ELISA阳性献血者在内的9例(45%)献血者免疫印迹反应结果不确定。免疫印迹模式因人而异,大多为弱反应性。总之,我们在美国胸腺瘤患者中未发现存在HTLV-I或HFV的证据。